Discover innovative solutions to the key challenges of the drug safety industry
Dr. Ahuja is currently Director, Asia Pacific for Baxter Healthcare. He is based in India and is responsible for driving the strategic direction, implementation and maintenance of a high performing Pharmacovigilance function for Baxter in Asia-Pacific. He has held vario…more ›
Dr. Beninger is Vice President of Global Patient Safety at Genzyme, a Sanofi Company in Cambridge, Massachusetts, where he is responsible for maintaining the global safety profile of the company’s cardio-renal and biosurgical device products. He began his career in dru…more ›
Milbhor D’Silva is a transplant and multiorgan procurement surgeon by background. His clinical work was complemented by live animal research using solid organ models of transplantation. His pharmaceutical medicine career spans 14 years. Over this period he has worked wi…more ›
Dr. Sylvia Dobo is a seasoned pharmacovigilance expert with over eight years industry experience. Prior to entering the pharmaceutical safety industry, she practiced full scope primary care while on faculty at the Feinberg School of Medicine, Northwestern University in …more ›
Steven has over 10 years of clinical research and global pharmacovigilance and pharmacoepidemiology experience. He’s currently Senior Director of Pharmacoviglance and Pharmacoepidemiology at AMAG Pharmaceuticals, overseeing all aspects of pre and post-marketing global d…more ›
Are you fully prepared to overcome the key drug safety challenges?
Come to the World Drug Safety Congress Americas and learn:
• Drug safety considerations specific to biopharmaceutical products
• Implementation of global harmonisation initiatives
• Post-marketing safety surveillance techniques and operations
• Risk minimization and management strategies
• Industry and regulatory view point of pv audits & inspections
Sponsors
The World Drug Safety Congress focuses on:
- International drug safety landscape
- Global regulatory overview and recent developments
- Increasing complexities affecting the management of drug safety
- Data management and electronic submissions
- Financial and logistical constraints
- In-depth look at clinical safety & the limitations to pre-marketing safety
Who should attend:
- Risk Management and Surveillance
- Clinical Safety
- Epidemiology
- Regulatory Affairs
- Qualified Person
- Electronic Submissions
- Pharmacovigilance
- Drug Safety
Who should sponsor:
- Who should sponsor:
- CROs
- Technology providers
World class solution providers attend:
- To showcase the latest services
- To meet senior pharma and biotech professionals
- To position their brand as a thought leader
- To generate leads and new business
